Get Real Stocks

ACHV · Achieve Life Sciences

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Country
United States

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

24h Volume by Exchange

No Data Yet

Issuer
Price
$6.79
24h Volume
-
Depth (±1%)
-